donortransmit
infect
common
potenti
seriou
complic
solid
organ
transplant
sot
rigor
screen
donor
latent
infect
essenti
optim
outcom
transplant
serv
prevent
inadvert
use
unsuit
organ
prompt
strateg
antiinfect
prophylaxi
infect
surveil
measur
posttransplant
chapter
provid
clinic
resourc
evalu
infect
risk
potenti
organ
donor
also
provid
basi
understand
geograph
restrict
donor
infect
increasingli
import
consider
transplant
medicin
direct
reader
number
recent
public
discuss
guidelin
pretransplant
infect
screen
organ
donor
recipi
comprehens
review
transmiss
tropic
geograph
restrict
infect
sot
also
publish
donor
infect
screen
begin
thorough
review
medic
social
histori
physic
examin
examin
may
provid
evid
activ
infect
inject
drug
use
nonprofession
tattoo
stigmata
undiagnos
infect
viral
exanthem
import
histor
data
includ
potenti
endem
travelrel
occup
recreat
exposur
infect
social
behavior
risk
factor
past
current
infect
paramount
import
ask
report
transmiss
donor
infect
transplant
center
includ
bacteri
infect
fungal
infect
suspect
sepsi
tuberculosi
central
nervou
system
infect
activ
viral
infect
serolog
evid
hiv
human
lymphotrop
context
solid
organ
transplant
screen
potenti
organ
donor
crucial
perform
great
rigor
minim
risk
transmiss
certain
infecti
process
review
aim
updat
understand
possibl
patholog
involv
well
emerg
infect
result
global
gain
increas
promin
daili
basi
elsevi
sl
right
reserv
viru
iii
htlv
iii
infect
parasit
protozo
infect
emerg
infect
repres
special
challeng
transplant
set
therefor
import
event
need
commun
transplant
center
serolog
microbiolog
test
donor
recommend
regulatori
bodi
profession
transplant
societi
summar
tabl
transmiss
hiv
via
organ
transplant
well
document
polici
regard
hiv
test
donor
candid
place
sinc
mani
countri
polici
regul
prohibit
organ
donat
hivinfect
person
although
recent
use
hivinfect
organ
hivinfect
kidney
recipi
perform
south
africa
donor
screen
enzymelink
immunoassay
eia
test
prefer
initi
test
repeatedli
reactiv
result
confirm
western
immunoblot
assay
wb
note
averag
window
period
infect
reactiv
eia
result
day
rang
day
hiv
nucleic
acid
test
nat
consider
see
section
highrisk
donor
organ
donor
screen
serolog
evid
hepat
b
viru
hbv
infect
immunoassay
hbv
surfac
antigen
hbsag
total
core
antibodi
hbcab
hbsag
donor
organ
gener
reserv
lifethreaten
case
hbsag
organ
may
consid
use
recipi
hbsag
protect
immun
hepat
result
immun
hbsab
titer
miuml
natur
infect
geograph
locat
hbv
hyperendem
posttransplant
hepat
b
immun
globulin
antivir
agent
administ
recipi
hbsag
organ
regardless
immun
statu
although
prophylaxi
prevent
transmiss
infect
case
recipi
requir
laboratori
monitor
acquir
hbv
common
scenario
potenti
donor
hbcab
hbv
serolog
profil
hbsag
hbcab
hbsab
may
appear
earli
hbv
infect
later
resolv
infect
altern
profil
sometim
repres
fals
posit
result
especi
risk
factor
hbv
absent
result
demonstr
hbcab
hbsab
consist
resolv
infect
although
hbv
may
persist
liver
risk
transmiss
infect
hbsag
hbcab
hbsabdonor
suscept
nonhepat
organ
recipi
low
recipi
protect
immun
requir
posttransplant
therapi
hbv
nonimmun
recipi
howev
undergo
serial
laboratori
test
hbv
infect
receiv
antivir
prophylaxi
agent
lamivudin
hepat
b
immun
globulin
donor
nat
hbv
may
use
assess
risk
transmiss
manag
recipi
hepat
c
viru
hcv
risk
viral
transmiss
infect
donor
seroneg
recipi
substanti
rang
recipi
acquir
hcv
risk
chronic
infect
progress
liver
diseas
cours
may
acceler
immunosuppress
therapi
especi
mycophenol
mofetil
prevent
inadvert
transmiss
hcv
donor
screen
eia
hcv
hcv
organ
gener
exclud
transplant
except
emerg
situat
often
preferenti
alloc
hcvinfect
recipi
fals
neg
test
result
occur
hcv
antibodi
test
mean
window
period
infect
seroconvers
day
consequ
transmiss
event
involv
hcv
seroneg
donor
occur
hcv
nat
test
donor
may
detect
infect
case
neg
antibodi
test
routin
perform
present
time
see
section
highrisk
donor
cytomegaloviru
cmv
donor
positiverecipi
neg
dr
serostatu
greatest
risk
factor
cmv
infect
posttransplant
although
cmv
r
may
develop
reactiv
diseas
r
donorrel
infect
dr
therefor
organ
donor
test
prior
latent
cmv
infect
eia
part
sot
risk
assess
appropri
surveil
andor
antivir
prophylaxi
institut
transplant
epsteinbarr
viru
ebv
infect
associ
develop
posttranspl
lymphoprolif
disord
ptld
greatest
risk
factor
ptld
drserostatu
thu
donor
serolog
screen
risk
assess
ebv
drrecipi
appropri
monitor
posttranspl
donor
screen
import
set
pediatr
transplant
younger
recipi
may
natur
acquir
infect
yet
seropreval
ebv
exce
adult
popul
donor
presum
posit
serolog
perform
base
past
medic
histori
physic
examin
donor
routin
screen
herpesviru
infect
herp
simplex
viru
varicella
zoster
viru
human
herpesvirus
transmiss
pallidum
organ
transplant
document
although
syphili
contraind
organ
donat
donor
screen
serolog
evid
nontreponem
assay
rapid
plasma
reagin
test
treponem
immunoassay
treatment
may
administ
recipi
serolog
reactiv
donor
organ
although
case
tuberculosi
tb
attribut
reactiv
latent
infect
recipi
donorderiv
tuberculosi
occur
therefor
live
donor
undergo
ppd
skin
test
result
posit
activ
tb
rule
donor
evalu
tb
cadaver
donor
reli
medic
histori
endem
exposur
radiograph
find
organ
donor
known
activ
tb
infect
gener
discard
lung
residu
tubercul
lesion
use
transplant
histori
latent
tb
without
evid
activ
infect
contraind
donat
administr
prevent
therapi
recipi
consid
interestingli
proven
case
transmiss
mycobacteria
tuberculosi
sepsi
bacteri
fungal
infect
frequent
identifi
potenti
organ
donor
consequ
intens
care
invas
resuscit
effort
donor
bacteremia
common
report
rate
infect
transmit
recipi
result
potenti
fatal
earli
posttranspl
complic
bacteremia
myocard
mycot
aneurysm
staphylococcu
aureu
pseudomona
aeruginosa
candida
spp
particular
propens
caus
seriou
complic
sepsi
infect
absolut
contraind
organ
donat
rather
antimicrobi
therapi
administ
donor
infect
identifi
premortem
recipi
reduc
risk
transmiss
similarli
organ
donor
bacteri
mening
use
success
long
donor
receiv
appropri
antibiot
therapi
premortem
identifi
subclin
infect
blood
urin
often
collect
time
organ
donat
especi
donor
hospit
hour
gener
recipi
receiv
organ
bacterem
fungem
donor
receiv
direct
antiinfect
therapi
period
day
lung
common
site
infect
donor
lung
transplant
consider
bronchoalveolar
lavag
bal
gram
stain
cultur
respiratori
secret
perform
donor
evid
gramposit
bacteri
infect
bloodstream
pneumonia
often
use
use
lung
gramneg
infect
controversi
expert
favor
discard
organ
other
advoc
use
aggress
antibiot
therapi
support
latter
argument
recent
retrospect
studi
demonstr
high
rate
transmiss
respiratori
tract
pathogen
lung
recipi
overal
patient
surviv
differ
recipi
uninfect
lung
infect
protozoan
gondii
extrem
common
seropreval
rate
europ
central
south
america
transmiss
infect
gondii
occur
commonli
seroneg
recipi
receiv
organ
seroposit
donor
wherea
occurr
toxoplasmosi
follow
abdomin
organ
transplant
low
preval
drheart
heartlung
recipi
absenc
antimicrobi
prophylaxi
rang
due
transmiss
cyst
present
within
cardiac
tissu
less
commonli
seroposit
recipi
may
manifest
reactiv
latent
infect
assess
risk
transmiss
organ
especi
heart
donor
screen
serolog
evid
infect
although
consist
practic
across
health
center
especi
region
low
endem
antiinfect
prophylaxi
trimethoprimsulfamethoxazol
routin
provid
highrisk
donor
due
rare
occurr
hiv
seroneg
donor
transmiss
hiv
regul
guidelin
put
place
reduc
transmiss
hiv
bloodborn
virus
organ
donat
guidelin
provid
social
behavior
medic
laboratori
criteria
identifi
donor
potenti
recent
hiv
infect
window
period
prior
seroconvers
possibl
infect
adequ
assess
due
hemodilut
lack
medic
histori
tabl
organ
donor
meet
criteria
gener
consid
recipi
lifethreaten
situat
addit
consent
must
obtain
recipi
expert
advoc
use
viral
nat
supplement
serolog
test
highrisk
donor
nat
window
period
infect
viral
detect
reduc
day
hiv
day
hcv
lesser
extent
day
day
hbv
neg
nat
result
may
provid
inform
risk
donor
viral
infect
maxim
organ
util
disadvantag
nat
expens
time
requir
addit
test
geograph
limit
avail
fals
posit
test
result
loss
organ
donor
main
inform
geograph
distribut
collect
tabl
brief
summari
particular
approach
provid
text
transmiss
histoplasmosi
describ
case
appear
result
reactiv
past
infect
recipi
serolog
test
perform
potenti
donor
live
area
endem
histori
pulmonari
diseas
within
past
year
radiograph
find
suggest
activ
past
histoplasmosi
calcifi
pulmonari
hilar
splenic
granulomata
nonendem
area
serolog
test
recommend
case
past
histori
travel
resid
endem
area
serolog
result
complement
fixat
cf
immunodiffus
id
affect
indic
transplant
acut
histoplasmosi
suspect
detect
antigen
urin
bal
fluid
csf
may
offer
rapid
diagnosi
nat
detect
h
capsulatum
blood
tissu
sampl
develop
use
itraconazol
prophylaxi
recipi
whose
donor
past
histori
histoplasmosi
controversi
nevertheless
cours
least
month
offer
least
lung
recipi
transmiss
coccidioidomycosi
lung
transplant
report
although
reactiv
latent
infect
recipi
appear
far
common
serolog
screen
eia
cf
id
recommend
donor
come
resid
area
endem
donor
histori
remot
coccidioidomycosi
radiolog
chang
prior
coccidioidomycosi
live
travel
area
endem
recipi
given
prophylaxi
oral
fluconazol
transplant
result
serolog
studi
becom
avail
posit
result
obtain
transplant
alreadi
perform
activ
ill
must
exclud
focu
found
prophylaxi
fluconazol
itraconazol
continu
month
fungi
region
fungal
infect
includ
paracoccidioid
brasiliensi
blastomyc
dermatitidi
penicillium
marneffei
clinician
radiologist
awar
possibl
p
brasiliensi
b
dermatitidi
infect
evalu
potenti
donor
latin
america
show
lung
skin
lesion
particularli
fail
identifi
acidfast
bacilli
sampl
report
case
infect
transmiss
via
graft
addit
routin
use
trimethoprimsulfamethoxazol
primari
prophylaxi
pneumocysti
jiroveci
pneumonia
also
effect
paracoccidioid
brasiliensi
screen
perform
donor
countri
endem
histori
recent
travel
two
three
preced
year
area
transmiss
malaria
recipi
document
detect
infect
necessarili
contraind
organ
donat
unless
caus
death
relat
malaria
case
organ
reject
diagnost
test
perform
examin
thick
thin
blood
film
stain
giemsa
field
wright
stain
techniqu
sensit
allow
estim
degre
parasitemia
well
identif
infect
speci
plasmodium
immunochromatographybas
techniqu
use
detect
low
level
parasitemia
parasit
person
report
nonmed
intraven
intramuscular
subcutan
inject
drug
preced
year
person
receiv
humanderiv
clot
factor
concentr
men
women
engag
sex
exchang
money
drug
preced
year
person
sex
preced
month
person
describ
item
person
known
suspect
hiv
infect
person
expos
preced
month
known
suspect
hivinfect
blood
percutan
inocul
contact
open
wound
nonintact
skin
mucou
membran
inmat
correct
system
addit
pediatr
donor
featur
children
meet
exclusionari
criteria
list
accept
donor
children
born
mother
hiv
infect
mother
meet
behavior
laboratori
exclusionari
criteria
adult
donor
regardless
hiv
statu
accept
donor
unless
hiv
infect
definit
exclud
child
follow
children
month
age
born
mother
risk
hiv
infect
breastf
within
last
month
whose
hiv
antibodi
test
physic
examin
review
medic
record
indic
evid
hiv
infect
may
accept
donor
transmiss
chaga
diseas
transplant
document
particularli
heart
transplant
chaga
diseas
rule
donor
resid
endem
area
use
serolog
test
mandatori
two
posit
result
use
differ
serolog
techniqu
immunofluoresc
antibodi
test
ifat
eia
necessari
consid
patient
infect
new
rapid
serolog
test
use
recombin
protein
immunochromatographi
cassett
test
may
use
emerg
situat
hour
preced
entamoeba
histolytica
amebiasi
central
south
america
africa
indian
subcontin
freeliv
amoeba
wide
distribut
environ
mainli
freshwat
river
stream
lake
swim
pool
water
treatment
system
case
peak
summer
month
trypanosoma
brucei
sleep
sick
trypanosoma
brucei
gambiens
west
central
africa
trypanosoma
brucei
rhodesiens
east
africa
transplant
procedur
identif
cruzi
giemsastain
thick
thin
blood
film
mean
concentr
techniqu
strout
method
micromethod
test
choic
diagnosi
acut
infect
nat
may
greater
sensit
specif
microscopi
acut
phase
may
detect
parasit
chronic
phase
circul
parasitemia
low
caus
death
deem
acut
chaga
diseas
donor
exclud
case
cardiac
transplant
use
heart
patient
chronic
infect
absolut
contraind
given
risk
develop
chagas
myocard
consensu
possibl
use
organ
infect
patient
heart
organ
infect
donor
transplant
close
followup
serolog
parasitolog
method
recommend
immedi
treatment
benznidazol
day
nifurtimox
day
start
upon
find
evid
infect
prophylaxi
diagnost
test
perform
donor
resid
travel
zone
endem
specif
treatment
recommend
prior
transplant
diagnosi
obtain
follow
visual
larva
stool
larval
cultur
examin
sever
sampl
recommend
use
special
microbiolog
techniqu
haradamori
larval
cultur
agar
medium
coliform
increas
sensit
diagnosi
echinococcu
spp
discoveri
imag
suggest
hydatid
cyst
prospect
organ
donor
area
endem
rais
suspicion
diagnosi
confirm
serolog
cyst
found
liver
bone
tend
produc
posit
serolog
greater
frequenc
locat
lung
brain
spleen
calcifi
cyst
intact
capsul
may
associ
neg
serolog
indirect
hemagglutin
assay
iha
ifat
eia
commonli
use
serolog
test
patient
neg
serolog
suspici
lesion
imag
punctur
aspir
lesion
perform
order
obtain
definit
diagnosi
organ
infect
hydatid
cyst
use
transplant
unless
cyst
local
inact
calcifi
permit
radic
excis
prior
transplant
isol
hepat
involv
organ
may
use
comput
tomographi
ct
scan
rule
extens
diseas
report
case
donor
infect
e
multiloculari
situat
aris
infect
organ
use
transplant
would
infiltr
diseas
ct
scan
perform
search
diseas
site
clinic
relev
trematod
includ
schistosoma
spp
haematobium
mansoni
japonicum
intercalatum
mekongi
fasciola
spp
clonorchi
spp
opistorchi
spp
paragonimu
spp
differ
organ
may
involv
mansoni
japonicum
involv
liver
haematobium
primarili
involv
urinari
tract
kidney
fasciola
spp
clonorchi
sinensi
opistorchi
spp
infect
affect
mainli
liver
bile
duct
pulmonari
involv
common
paragonimu
spp
infect
extrapulmonari
manifest
occur
rare
use
diagnost
test
donor
area
endem
recommend
especi
presenc
peripher
blood
eosinophilia
screen
test
intestin
hepat
trematodias
clonorchi
spp
opistorchi
spp
intestin
schistosomias
mansoni
japonicum
intercalatum
made
direct
visual
parasit
ova
fece
paragonimiasi
diagnos
direct
visual
ova
sputum
stool
specimen
case
genitourinari
schistosomiasi
haematobium
ova
visual
urin
specimen
posit
find
would
necessarili
contraind
transplant
specif
treatment
administ
case
close
monitor
due
risk
possibl
longterm
complic
parasit
pathogen
includ
leishmania
spp
filaria
wuchereria
bancrofti
brugia
malayi
onchocerca
volvulu
loa
loa
babesia
spp
entamoeba
histolytica
amebiasi
freeliv
ameba
trypanosoma
brucei
taenia
solium
cysticercosi
routin
serolog
screen
organ
donor
area
endem
would
advoc
due
lack
definit
evid
transmiss
leishmania
spp
transplant
graft
avail
donor
serolog
known
posit
strict
monitor
recipi
posttranspl
period
would
recommend
rather
reject
organ
peripher
blood
smear
may
screen
lysiscentrifug
giemsa
stain
high
index
suspicion
infect
filaria
donor
could
treat
prior
transplant
result
posit
document
case
transmiss
babesia
spp
e
histolytica
directli
via
infect
graft
screen
test
routin
necessari
risk
transmiss
naegleria
organ
donat
unknown
possibl
patient
die
due
enceph
gener
reject
potenti
organ
donor
new
nat
becom
readili
avail
test
avail
exclud
freeliv
ameba
infect
current
prophylact
treatment
regimen
establish
describ
case
transmiss
human
african
trypanosomiasi
sot
due
sever
prognosi
diseas
toxic
treatment
organ
come
known
infect
donor
reject
donor
area
endem
clinic
symptom
sign
suggest
cysticercosi
wb
may
perform
serolog
may
posit
patient
live
area
endem
reflect
exposur
rather
infect
may
fals
neg
due
decreas
sensit
cyst
calcifi
number
use
organ
patient
neurocysticercosi
would
contraind
given
cyst
occur
central
nervou
ocular
subcutan
tissu
skelet
muscl
nevertheless
cyst
may
aris
cardiac
muscl
thu
imag
techniqu
donor
heart
may
perform
togeth
neg
serolog
rule
infect
organ
determin
donor
htlv
iii
statu
base
primarili
result
obtain
eia
sampl
initi
test
posit
retest
order
decreas
risk
falseposit
result
due
technic
error
time
perform
confirmatori
assay
wb
radioimmunoprecipit
alway
readili
avail
may
save
organ
donat
reject
falseposit
screen
test
howev
long
delay
confirmatori
test
may
also
lead
loss
graft
nat
could
potenti
specif
identifi
falseposit
donor
howev
current
commerci
avail
nat
turnaround
time
short
enough
solv
problem
donor
htlv
reactiv
eia
countri
low
seropreval
htlv
iii
current
polici
mandatori
test
antihtlv
antibodi
appli
organ
donor
come
area
htlv
endem
high
suspicion
htlv
infect
major
organ
procur
organ
polici
reject
organ
htlv
iii
posit
donor
howev
use
donor
may
consid
case
lifethreaten
situat
particularli
older
recipi
appropri
inform
consent
decis
base
seri
document
transmiss
potenti
donor
meningoencephalit
myelit
symptom
undetermin
etiolog
resid
specif
geograph
area
period
usual
two
week
human
wnv
activ
exclud
transmiss
infect
well
document
screen
test
base
specif
antibodi
detect
use
antibodi
appear
week
infect
persist
month
screen
method
base
nat
close
time
donat
possibl
virem
donor
reject
rabi
viru
caus
acut
enceph
question
patient
rel
possibl
contact
bat
anywher
world
mammalian
bite
abroad
identifi
patient
risk
also
potenti
donor
unexplain
neurolog
symptom
evalu
possibl
cn
infect
even
minim
risk
infect
donor
test
rabi
viru
transplant
skin
biopsi
saliva
test
prefer
brain
biopsi
virusneutr
antibodi
serum
measur
use
viru
neutral
test
rapid
fluoresc
focu
inhibit
test
fluoresc
antibodi
viru
neutral
test
tend
appear
averag
day
clinic
symptom
appear
viral
antigen
may
also
detect
use
ifat
skin
biopsi
nat
may
perform
detect
rabi
viru
sever
biolog
fluid
sampl
eg
saliva
csf
tear
skin
biopsi
sampl
urin
time
restraint
specif
diagnost
test
avail
anyon
histori
possibl
exposur
rabi
viru
accept
donor
transmiss
infect
fatal
outcom
observ
